These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8481394)

  • 61. Cholesterol transfer from low density lipoproteins to reconstituted high density lipoproteins is determined by the properties and concentrations of both particles.
    Bottum K; Jonas A
    Biochemistry; 1995 May; 34(21):7264-70. PubMed ID: 7766638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
    Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
    Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase.
    Blatter MC; James RW; Messmer S; Barja F; Pometta D
    Eur J Biochem; 1993 Feb; 211(3):871-9. PubMed ID: 8382160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apolipoprotein A-I localization and dipalmitoylphosphatidylcholine dynamics in reconstituted high density lipoproteins.
    Dergunov AD; Dobretsov GE
    Chem Phys Lipids; 2000 Feb; 104(2):161-73. PubMed ID: 10669308
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography.
    Nanjee MN; Brinton EA
    Clin Chem; 2000 Feb; 46(2):207-23. PubMed ID: 10657377
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stoichiometry of reconstituted high-density lipoproteins in the hydrated state determined by photon antibunching.
    Ly S; Petrlova J; Huser T; Fore S; Gao T; Voss J; Laurence TA
    Biophys J; 2011 Aug; 101(4):970-5. PubMed ID: 21843489
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lp(a) and the risk of coronary heart disease.
    Bihari-Varga M; Kostner G; Czinner A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():33-5. PubMed ID: 1387093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications.
    Lerch PG; Förtsch V; Hodler G; Bolli R
    Vox Sang; 1996; 71(3):155-64. PubMed ID: 8912458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Shared and unique genetic effects among seven HDL phenotypes.
    Comuzzie AG; Rainwater DL; Blangero J; Mahaney MC; VandeBerg JL; MacCluer JW
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):859-64. PubMed ID: 9157948
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High density lipoprotein exchange reactions.
    Loeb J; Dawson G
    Mol Cell Biochem; 1983; 52(2):161-76. PubMed ID: 6410179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II.
    Melchior JT; Street SE; Vaisar T; Hart R; Jerome J; Kuklenyik Z; Clouet-Foraison N; Thornock C; Bedi S; Shah AS; Segrest JP; Heinecke JW; Davidson WS
    J Lipid Res; 2021; 62():100099. PubMed ID: 34324889
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formation of HDL-like complexes from apolipoprotein A-I(M) and DMPC.
    Suurkuusk M; Singh SK
    Int J Pharm; 2000 Jan; 194(1):21-38. PubMed ID: 10601682
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The covalent structure of apolipoprotein A-I from canine high density lipoproteins.
    Chung H; Randolph A; Reardon I; Heinrikson RL
    J Biol Chem; 1982 Mar; 257(6):2961-7. PubMed ID: 6801039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proapolipoprotein-converting enzymes and high-density lipoprotein early events in biogenesis.
    Scanu AM
    Am Heart J; 1987 Feb; 113(2 Pt 2):527-32. PubMed ID: 3544766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Very low high-density lipoproteins without coronary atherosclerosis.
    Rader DJ; Ikewaki K; Duverger N; Feuerstein I; Zech L; Connor W; Brewer HB
    Lancet; 1993 Dec; 342(8885):1455-8. PubMed ID: 7902482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipid-protein interaction at solid-water interface. Adsorption of human apo-high density lipoprotein to amphiphilic interfaces.
    Shen BW
    J Biol Chem; 1985 Jan; 260(2):1032-9. PubMed ID: 3918025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interaction of apolipoprotein A-I with lecithin-cholesterol vesicles in the presence of phospholipase C.
    Gudheti MV; Gonzalez YI; Lee SP; Wrenn SP
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):127-41. PubMed ID: 14729075
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties.
    Calvo C; Talussot C; Ponsin G; Berthézène F
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1060-7. PubMed ID: 3134018
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatment.
    Menschikowski M; Hempel U; Dinnebier G; Lattke P; Wenzel KW; Jaross W
    Atherosclerosis; 1995 Oct; 117(2):159-67. PubMed ID: 8801861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization and measurement of human apolipoprotein A-II by radioimmunoassay.
    Goldberg RB; Karlin JB; Juhn DJ; Scanu AM; Edelstein C; Rubenstein AH
    J Lipid Res; 1980 Sep; 21(7):902-12. PubMed ID: 6777442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.